Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed regarding loss of share certificate(s) received on 13th July, 2023, details enclosed. The company is in the process of issuing Letter of Confirmation, after compliance of required formalities.
The above information is a part of company’s filings submitted to BSE.